company background image
4155 logo

OK Biotech TWSE:4155 Stock Report

Last Price

NT$23.80

Market Cap

NT$3.5b

7D

-0.8%

1Y

-22.0%

Updated

24 Apr, 2024

Data

Company Financials

4155 Stock Overview

OK Biotech Co., Ltd. manufactures, markets, and sells blood glucose monitoring devices and related homecare medical products worldwide.

4155 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends1/6

OK Biotech Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for OK Biotech
Historical stock prices
Current Share PriceNT$23.80
52 Week HighNT$41.37
52 Week LowNT$23.65
Beta0.33
1 Month Change-1.45%
3 Month Change-4.23%
1 Year Change-22.05%
3 Year Change-1.94%
5 Year Change-11.98%
Change since IPO72.24%

Recent News & Updates

Recent updates

OK Biotech Co., Ltd. (TPE:4155) Investors Should Think About This Before Buying It For Its Dividend

Apr 26
OK Biotech Co., Ltd. (TPE:4155) Investors Should Think About This Before Buying It For Its Dividend

Calculating The Fair Value Of OK Biotech Co., Ltd. (TPE:4155)

Apr 04
Calculating The Fair Value Of OK Biotech Co., Ltd. (TPE:4155)

OK Biotech (TPE:4155) Has A Pretty Healthy Balance Sheet

Mar 17
OK Biotech (TPE:4155) Has A Pretty Healthy Balance Sheet

Has OK Biotech (TPE:4155) Got What It Takes To Become A Multi-Bagger?

Mar 01
Has OK Biotech (TPE:4155) Got What It Takes To Become A Multi-Bagger?

Is OK Biotech Co., Ltd.'s (TPE:4155) Recent Price Movement Underpinned By Its Weak Fundamentals?

Feb 15
Is OK Biotech Co., Ltd.'s (TPE:4155) Recent Price Movement Underpinned By Its Weak Fundamentals?

A Look At OK Biotech's (TPE:4155) Share Price Returns

Jan 31
A Look At OK Biotech's (TPE:4155) Share Price Returns

We Wouldn't Rely On OK Biotech's (TPE:4155) Statutory Earnings As A Guide

Jan 17
We Wouldn't Rely On OK Biotech's (TPE:4155) Statutory Earnings As A Guide

Consider This Before Buying OK Biotech Co., Ltd. (TPE:4155) For The 5.4% Dividend

Jan 03
Consider This Before Buying OK Biotech Co., Ltd. (TPE:4155) For The 5.4% Dividend

Estimating The Intrinsic Value Of OK Biotech Co., Ltd. (TPE:4155)

Dec 21
Estimating The Intrinsic Value Of OK Biotech Co., Ltd. (TPE:4155)

Here's Why OK Biotech (TPE:4155) Can Manage Its Debt Responsibly

Dec 08
Here's Why OK Biotech (TPE:4155) Can Manage Its Debt Responsibly

Should You Be Impressed By OK Biotech's (TPE:4155) Returns on Capital?

Nov 23
Should You Be Impressed By OK Biotech's (TPE:4155) Returns on Capital?

Shareholder Returns

4155TW Medical EquipmentTW Market
7D-0.8%1.0%-1.6%
1Y-22.0%5.3%25.9%

Return vs Industry: 4155 underperformed the TW Medical Equipment industry which returned 5.3% over the past year.

Return vs Market: 4155 underperformed the TW Market which returned 25.9% over the past year.

Price Volatility

Is 4155's price volatile compared to industry and market?
4155 volatility
4155 Average Weekly Movement2.1%
Medical Equipment Industry Average Movement4.6%
Market Average Movement4.6%
10% most volatile stocks in TW Market8.6%
10% least volatile stocks in TW Market2.2%

Stable Share Price: 4155 has not had significant price volatility in the past 3 months.

Volatility Over Time: 4155's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2006n/an/awww.okbiotech.com

OK Biotech Co., Ltd. manufactures, markets, and sells blood glucose monitoring devices and related homecare medical products worldwide. It also provides glucometers and blood glucose test strips; nebulizer, portable nebulizer, and mesh nebulizer and test strips; and personal sound amplifiers. The company was founded in 2006 and is headquartered in Hsinchu City, Taiwan.

OK Biotech Co., Ltd. Fundamentals Summary

How do OK Biotech's earnings and revenue compare to its market cap?
4155 fundamental statistics
Market capNT$3.48b
Earnings (TTM)NT$2.95m
Revenue (TTM)NT$1.19b

1,177x

P/E Ratio

2.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4155 income statement (TTM)
RevenueNT$1.19b
Cost of RevenueNT$995.10m
Gross ProfitNT$196.88m
Other ExpensesNT$193.94m
EarningsNT$2.95m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.02
Gross Margin16.52%
Net Profit Margin0.25%
Debt/Equity Ratio13.6%

How did 4155 perform over the long term?

See historical performance and comparison

Dividends

1.3%

Current Dividend Yield

1,305%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.